세계의 승모판 질환 시장 보고서(2025년)

Mitral valve disease affects the mitral valve, which regulates blood flow between the heart's left atrium and left ventricle. This disorder can cause narrowing or leakage of the valve, disrupting normal blood circulation and leading to symptoms such as breathlessness, fatigue, and irregular heart rhythms. The primary goal in managing mitral valve disease is to maintain proper blood flow through the heart and prevent complications.

Key treatments for mitral valve disease include mitral valve repair, mitral valve replacement, cardiac resynchronization therapy, and mitral valve therapeutics. Mitral valve repair involves surgical or minimally invasive procedures to correct defects or leaks in the mitral valve, aiming to restore its normal function and prevent further health issues. This treatment is used to address conditions such as mitral valve stenosis, mitral valve prolapse, and mitral valve regurgitation, and is administered in settings such as hospitals and ambulatory surgical centers.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The mitral valve disease market research report is one of a series of new reports from The Business Research Company that provides mitral valve disease market statistics, including the mitral valve disease industry global market size, regional shares, competitors with mitral valve disease market share, detailed mitral valve disease market segments, market trends, and opportunities, and any further data you may need to thrive in the mitral valve disease industry. These mitral valve disease market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The mitral valve disease market size has grown strongly in recent years. It will grow from $3 billion in 2024 to $3.28 billion in 2025 at a compound annual growth rate (CAGR) of 9.1%. The growth in the historic period can be attributed to patient education initiatives, adequate reimbursement policies and insurance coverage, growing healthcare expenditure, rising awareness and screening efforts, and expanding market presence.

The mitral valve disease market size is expected to see strong growth in the next few years. It will grow to $4.65 billion in 2029 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to growing prevalence of mitral valve disease, increasing adoption for minimally invasive techniques, soaring innovations in heart valve surgery, rise venture capital investments, and rising interest of manufacturers. Major trends in the forecast period include technological advancements, advancements in transcatheter technologies, and increasing technological advancements in surgical procedures.

The forecast of 9.2% growth over the next five years reflects a modest reduction of 0.3% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. hospitals by driving up the cost of transcatheter mitral valve repair systems and 3D echocardiography equipment sourced from Israel and the Netherlands, exacerbating treatment delays and elevating cardiology department budgets. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising prevalence of vascular heart diseases is expected to drive the growth of the mitral valve disease market in the coming years. Vascular heart diseases refer to a group of conditions that impact the blood vessels supplying the heart or the heart itself. A combination of lifestyle choices, demographic changes, medical conditions, environmental influences, and genetic factors contributes to the increasing incidence of vascular heart diseases. Conditions such as ischemic heart disease and hypertension can indirectly lead to mitral valve disease by affecting the heart's structure and function, resulting in complications involving the mitral valve. For example, in June 2024, the Australian Bureau of Statistics reported that the death rate from cardiovascular disease per 100,000 population increased from 143.7 in 2021 to 148.2 in 2022 for males, according to data from the National Health Survey conducted by the Australian Institute of Health and Welfare. As a result, the growing prevalence of vascular heart diseases is driving the mitral valve disease market.

Key companies in the mitral valve disease market are developing stented tissue valves to meet the rising demand for minimally invasive treatment options. These valves are designed to offer durable and reliable performance, providing an alternative to traditional surgical methods. For example, in April 2024, Medtronic, an Ireland-based healthcare company, introduced the Avalus Ultra valve, an advanced surgical aortic tissue valve aimed at improving ease of use during implantation and long-term patient management. Building on a decade of clinical experience with the original Avalus valve, the Avalus Ultra features a low-profile valve for easier implantation, a PEEK base frame for consistent circularity, and an industry-leading Effective Orifice Area (EOA), which may enhance blood flow. Additionally, it incorporates a radiopaque coil for better visibility during future valve-in-valve procedures.

In July 2024, Edwards Lifesciences, a US-based medical technology company, acquired Innovative Bio Medical Ltd. for an undisclosed amount. This acquisition is aimed at strengthening Edwards Lifesciences' portfolio of transcatheter mitral valve replacement (TMVR) technologies, helping the company better address unmet needs in structural heart disease and supporting long-term growth. Innovative Bio Medical Ltd., a UK-based medical device company, specializes in developing advanced TMVR technologies.

Major companies operating in the mitral valve disease market are Pfizer Inc., Bayer AG, Abbott Laboratories, Novartis AG, Medtronic plc, Boston Scientific Corporation, Edwards Lifesciences, ShockWave Medical Inc., Artivion Inc., TTK Health Care Limited, Braile Biomedica, JenaValve Technology Inc., 4C Medical technologies, Labcor Laboratorios Ltda, CryoLife Inc., Valcare Medical, Affluent Medical, Colibri Heart Valve LLC, Coramaze Technologies, Corcym UK Limited, HighLife Medical, Micro International Devices Inc., Neovasc Inc., Mitralign Inc., Transcatheter Technologies GmbH

Europe was the largest region in the mitral valve disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mitral valve disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the mitral valve disease market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The mitral valve disease market includes revenues earned by entities by providing services such as diagnostic imaging, surgical, and interventional procedures, alongside consultation, rehabilitation, and telemedicine services, catering to patient care and research needs. The market value includes the value of related goods sold by the service provider or included within the service offering. The mitral valve disease market also includes sales of valve repair devices, valve replacement devices, imaging and diagnostic tools. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Mitral Valve Disease Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on mitral valve disease market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for mitral valve disease ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The mitral valve disease market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Treatment Type: Mitral Valve Repair; Mitral Valve Replacement; Cardiac Resynchronization Therapy; Mitral Valve Therapeutics
• 2) By Indication: Mitral Valve Stenosis; Mitral Valve Prolapse; Mitral Valve Regurgitation
• 3) By End-User: Hospitals; Ambulatory Surgical Centers; Other End-Users
• Subsegments:
• 1) By Mitral Valve Repair: Surgical Repair; Minimally Invasive Repair; Percutaneous Mitral Valve Repair
• 2) By Mitral Valve Replacement: Mechanical Valve Replacement; Biological Valve Replacement; Transcatheter Mitral Valve Replacement (TMVR)
• 3) By Cardiac Resynchronization Therapy: Pacemaker Therapy; Implantable Cardioverter-Defibrillators (ICD); Biventricular Pacing
• 4) By Mitral Valve Therapeutics: Pharmacological Treatments; Anticoagulation Therapy; Mitral Valve Repair Devices
• Companies Mentioned: Pfizer Inc.; Bayer AG; Abbott Laboratories; Novartis AG; Medtronic plc; Boston Scientific Corporation; Edwards Lifesciences; ShockWave Medical Inc.; Artivion Inc.; TTK Health Care Limited; Braile Biomedica; JenaValve Technology Inc.; 4C Medical technologies; Labcor Laboratorios Ltda; CryoLife Inc.; Valcare Medical; Affluent Medical; Colibri Heart Valve LLC; Coramaze Technologies; Corcym UK Limited; HighLife Medical; Micro International Devices Inc.; Neovasc Inc.; Mitralign Inc.; Transcatheter Technologies GmbH
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Mitral Valve Disease Market Characteristics

3. Mitral Valve Disease Market Trends And Strategies

4. Mitral Valve Disease Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Mitral Valve Disease Growth Analysis And Strategic Analysis Framework

• 5.1. Global Mitral Valve Disease PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Mitral Valve Disease Market Growth Rate Analysis
• 5.4. Global Mitral Valve Disease Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Mitral Valve Disease Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Mitral Valve Disease Total Addressable Market (TAM)

6. Mitral Valve Disease Market Segmentation

• 6.1. Global Mitral Valve Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Mitral Valve Repair
• Mitral Valve Replacement
• Cardiac Resynchronization Therapy
• Mitral Valve Therapeutics
• 6.2. Global Mitral Valve Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Mitral Valve Stenosis
• Mitral Valve Prolapse
• Mitral Valve Regurgitation
• 6.3. Global Mitral Valve Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Ambulatory Surgical Centres
• Other End-Users
• 6.4. Global Mitral Valve Disease Market, Sub-Segmentation Of Mitral Valve Repair, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Surgical Repair
• Minimally Invasive Repair
• Percutaneous Mitral Valve Repair
• 6.5. Global Mitral Valve Disease Market, Sub-Segmentation Of Mitral Valve Replacement, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Mechanical Valve Replacement
• Biological Valve Replacement
• Transcatheter Mitral Valve Replacement (TMVR)
• 6.6. Global Mitral Valve Disease Market, Sub-Segmentation Of Cardiac Resynchronization Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pacemaker Therapy
• Implantable Cardioverter-Defibrillators (ICD)
• Biventricular Pacing
• 6.7. Global Mitral Valve Disease Market, Sub-Segmentation Of Mitral Valve Therapeutics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmacological Treatments
• Anticoagulation Therapy
• Mitral Valve Repair Devices

7. Mitral Valve Disease Market Regional And Country Analysis

• 7.1. Global Mitral Valve Disease Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Mitral Valve Disease Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Mitral Valve Disease Market

• 8.1. Asia-Pacific Mitral Valve Disease Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Mitral Valve Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Mitral Valve Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Mitral Valve Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Mitral Valve Disease Market

• 9.1. China Mitral Valve Disease Market Overview
• 9.2. China Mitral Valve Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Mitral Valve Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Mitral Valve Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Mitral Valve Disease Market

• 10.1. India Mitral Valve Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Mitral Valve Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Mitral Valve Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Mitral Valve Disease Market

• 11.1. Japan Mitral Valve Disease Market Overview
• 11.2. Japan Mitral Valve Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Mitral Valve Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Mitral Valve Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Mitral Valve Disease Market

• 12.1. Australia Mitral Valve Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Mitral Valve Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Mitral Valve Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Mitral Valve Disease Market

• 13.1. Indonesia Mitral Valve Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Mitral Valve Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Mitral Valve Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Mitral Valve Disease Market

• 14.1. South Korea Mitral Valve Disease Market Overview
• 14.2. South Korea Mitral Valve Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Mitral Valve Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Mitral Valve Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Mitral Valve Disease Market

• 15.1. Western Europe Mitral Valve Disease Market Overview
• 15.2. Western Europe Mitral Valve Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Mitral Valve Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Mitral Valve Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Mitral Valve Disease Market

• 16.1. UK Mitral Valve Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Mitral Valve Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Mitral Valve Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Mitral Valve Disease Market

• 17.1. Germany Mitral Valve Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Mitral Valve Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Mitral Valve Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Mitral Valve Disease Market

• 18.1. France Mitral Valve Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Mitral Valve Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Mitral Valve Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Mitral Valve Disease Market

• 19.1. Italy Mitral Valve Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Mitral Valve Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Mitral Valve Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Mitral Valve Disease Market

• 20.1. Spain Mitral Valve Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Mitral Valve Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Mitral Valve Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Mitral Valve Disease Market

• 21.1. Eastern Europe Mitral Valve Disease Market Overview
• 21.2. Eastern Europe Mitral Valve Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Mitral Valve Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Mitral Valve Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Mitral Valve Disease Market

• 22.1. Russia Mitral Valve Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Mitral Valve Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Mitral Valve Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Mitral Valve Disease Market

• 23.1. North America Mitral Valve Disease Market Overview
• 23.2. North America Mitral Valve Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Mitral Valve Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Mitral Valve Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Mitral Valve Disease Market

• 24.1. USA Mitral Valve Disease Market Overview
• 24.2. USA Mitral Valve Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Mitral Valve Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Mitral Valve Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Mitral Valve Disease Market

• 25.1. Canada Mitral Valve Disease Market Overview
• 25.2. Canada Mitral Valve Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Mitral Valve Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Mitral Valve Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Mitral Valve Disease Market

• 26.1. South America Mitral Valve Disease Market Overview
• 26.2. South America Mitral Valve Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Mitral Valve Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Mitral Valve Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Mitral Valve Disease Market

• 27.1. Brazil Mitral Valve Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Mitral Valve Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Mitral Valve Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Mitral Valve Disease Market

• 28.1. Middle East Mitral Valve Disease Market Overview
• 28.2. Middle East Mitral Valve Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Mitral Valve Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Mitral Valve Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Mitral Valve Disease Market

• 29.1. Africa Mitral Valve Disease Market Overview
• 29.2. Africa Mitral Valve Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Mitral Valve Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Mitral Valve Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Mitral Valve Disease Market Competitive Landscape And Company Profiles

• 30.1. Mitral Valve Disease Market Competitive Landscape
• 30.2. Mitral Valve Disease Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis

31. Mitral Valve Disease Market Other Major And Innovative Companies

• 31.1. Boston Scientific Corporation
• 31.2. Edwards Lifesciences
• 31.3. ShockWave Medical Inc.
• 31.4. Artivion Inc.
• 31.5. TTK Health Care Limited
• 31.6. Braile Biomedica
• 31.7. JenaValve Technology Inc.
• 31.8. 4C Medical technologies
• 31.9. Labcor Laboratorios Ltda
• 31.10. CryoLife Inc.
• 31.11. Valcare Medical
• 31.12. Affluent Medical
• 31.13. Colibri Heart Valve LLC
• 31.14. Coramaze Technologies
• 31.15. Corcym UK Limited

32. Global Mitral Valve Disease Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Mitral Valve Disease Market

34. Recent Developments In The Mitral Valve Disease Market

35. Mitral Valve Disease Market High Potential Countries, Segments and Strategies

• 35.1 Mitral Valve Disease Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Mitral Valve Disease Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Mitral Valve Disease Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer